Skip Nav Destination
Issue Archive
Table of Contents
PHOTOGRAPHS
REVIEW
ARTICLES
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy
DE Reece,MJ Barnett,JD Shepherd,DE Hogge,RJ Klasa,SH Nantel,HJ Sutherland,HG Klingemann,RN Fairey,NJ Voss
A randomized placebo-controlled phase III study of granulocyte- macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)
JM Rowe,JW Andersen,JJ Mazza,JM Bennett,E Paietta,FA Hayes,D Oette,PA Cassileth,EA Stadtmauer,PH Wiernik
MULTICENTER STUDY
LETTER
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals